Wells Fargo’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q2 | – | Sell |
-63,924
| Closed | -$3.42M | – | 6390 |
|
2016
Q1 | $3.42M | Sell |
63,924
-2,153
| -3% | -$115K | ﹤0.01% | 2545 |
|
2015
Q4 | $7.47M | Buy |
66,077
+5,625
| +9% | +$635K | ﹤0.01% | 2037 |
|
2015
Q3 | $7.12M | Buy |
60,452
+5,292
| +10% | +$623K | ﹤0.01% | 2046 |
|
2015
Q2 | $4.27M | Sell |
55,160
-1,338
| -2% | -$104K | ﹤0.01% | 2509 |
|
2015
Q1 | $3.27M | Sell |
56,498
-1,928
| -3% | -$112K | ﹤0.01% | 2656 |
|
2014
Q4 | $1.89M | Sell |
58,426
-4,151
| -7% | -$134K | ﹤0.01% | 3021 |
|
2014
Q3 | $1.53M | Buy |
62,577
+10,338
| +20% | +$253K | ﹤0.01% | 3147 |
|
2014
Q2 | $926K | Buy |
52,239
+246
| +0.5% | +$4.36K | ﹤0.01% | 3535 |
|
2014
Q1 | $1.04M | Buy |
51,993
+48,693
| +1,476% | +$975K | ﹤0.01% | 3435 |
|
2013
Q4 | $55K | Buy |
+3,300
| New | +$55K | ﹤0.01% | 4633 |
|